M Miyazu
About
In The Last Decade
M Miyazu
23 papers receiving 396 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 180
- Cell Biology 122
- Immunology and Allergy 59
- Epidemiology 46
- Biomedical Engineering 40
Countries citing papers authored by M Miyazu
This map shows the geographic impact of M Miyazu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Miyazu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Miyazu more than expected).
Fields of papers citing papers by M Miyazu
This network shows the impact of papers produced by M Miyazu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Miyazu. The network helps show where M Miyazu may publish in the future.
Co-authorship network of co-authors of M Miyazu
This figure shows the co-authorship network connecting the top 25 collaborators of M Miyazu. A scholar is included among the top collaborators of M Miyazu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Miyazu. M Miyazu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | 66 | |
| 3 | 87 | |
| 4 | 17 | |
| 5 | 38 | |
| 6 | [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics]. | 2 |
| 7 | 9 | |
| 8 | [Laboratory and clinical evaluation of meropenem in pediatric field]. | 4 |
| 9 | [A study of the absorption and excretion of fosfomycin sodium in children]. | 8 |
| 10 | [Laboratory and clinical evaluations of flomoxef sodium in neonates]. | 1 |
| 11 | [Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics]. | 1 |
| 12 | [Pharmacokinetic, bacteriological and clinical evaluation of cefpodoxime proxetil in pediatrics]. | 6 |
| 13 | [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates]. | 6 |
| 14 | [Studies on sulbactam/ampicillin in the field of pediatrics]. | 2 |
| 15 | [Studies on sultamicillin in the field of pediatrics]. | 1 |
| 16 | [Studies on imipenem/cilastatin sodium in the field of pediatrics]. | 1 |
| 17 | 13 | |
| 18 | Studies on live attenuated mumps vaccine. III. Long-term follow-up study on the efficacy of Biken vaccine. | 1 |
| 19 | 11 | |
| 20 | [Laboratory and clinical studies of cefoperazone in children (author's transl)]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.